Catherine L. Cioffi - Concepedia

Author

Catherine L. Cioffi

Novartis (Switzerland)

Also Known As

C L Cioffi, C. CIOFFI, C. Cioffi, C. L. Cioffi, Catherine Cioffi, Catherine L Cioffi, Catherine L. Cioffi

Publications

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)University of Maryland, Baltimore Ionis Pharmaceuticals (United States)

About

Catherine L. Cioffi is an author at Novartis (Switzerland) specializing in medicine, cell biology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	373
2	Biochemistry	3	3	195
3	Natural Sciences	2	2	185
4	Social Sciences	2	2	35
5	Biomedical Engineering	1	1	48

Catherine L. Cioffi

Publications

Citations

H-Index

Page 1

	Year	Citations
Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors Elisabeth Buchdunger, Catherine L. Cioffi, Norman M. Law, Journal of Pharmacology and Experimental Therapeutics	2000	1.3K
Differential regulation of HIF-1α prolyl-4-hydroxylase genes by hypoxia in human cardiovascular cells Catherine L. Cioffi, Xiaoqin Liu, Penelope A. Kosinski, Biochemical and Biophysical Research Communications Redox SignalingHif-1α Prolyl-4-hydroxylase GenesBiochemistryRedox RegulatorNatural Sciences	2003	173
Inhibition of C-Jun N-Terminal Kinase 1, but Not c-Jun N-Terminal Kinase 2, Suppresses Apoptosis Induced by Ischemia/Reoxygenation in Rat Cardiac Myocytes David Hreniuk, Michele Garay, William A. Gaarde, Molecular Pharmacology	2001	117
Gene therapy vector-mediated expression of insulin-like growth factors protects cardiomyocytes from apoptosis and enhances neovascularization Enming J. Su, Catherine L. Cioffi, Steingrimur Stefansson, American Journal of Physiology-Heart and Circulatory Physiology Heart FailureInsulin-like Growth FactorsIgf VectorsBiomedical EngineeringCardiovascular Translational Research	2003	48
Selective Inhibition of A-Raf and C-Raf mRNA Expression by Antisense Oligodeoxynucleotides in Rat Vascular Smooth Muscle Cells: Role of A-Raf and C-Raf in Serum-Induced Proliferation Catherine L. Cioffi, M Garay, Joseph F. Johnston, Molecular Pharmacology	1997	47
Short-term desensitization of muscarinic cholinergic receptors in mouse neuroblastoma cells: selective loss of agonist low-affinity and pirenzepine high-affinity binding sites. Catherine L. Cioffi, Esam E. El‐Fakahany Journal of Pharmacology and Experimental Therapeutics	1986	46
Inhibition of hypoxia/reoxygenation-induced apoptosis by an antisense oligonucleotide targeted to JNK1 in human kidney cells Michelle Garay, William A. Gaarde, Brett P. Monia, Biochemical Pharmacology Redox RegulatorMedicineApoptosisHypoxia (Medicine)Cell Death	2000	37
Novel Qualitative Structure-Activity Relationships for the Antinociceptive Actions of H2 Antagonists, H3Antagonists and Derivatives Lindsay B. Hough, Julia W. Nalwalk, B. Y. Li, Journal of Pharmacology and Experimental Therapeutics	1997	31
Reduction of Muscarinic Receptor Density and of Guanine Nucleotide‐Stimulated Phosphoinositide Hydrolysis in Human SH‐SY5Y Neuroblastoma Cells Following Long‐Term Treatment with 12‐<i>O</i>‐Tetradecanoylphorbol 13‐Acetate or Mezerein Catherine L. Cioffi, Stephen K. Fisher Journal of Neurochemistry	1990	27
Differential sensitivity of phosphoinositide and cyclic gmp responses to short-term regulation by a muscarinic agonist in mouse neuroblastoma cells Catherine L. Cioffi, Esam E. El‐Fakahany Biochemical Pharmacology Molecular PhysiologySignal TransductionMouse Neuroblastoma CellsMuscarinic AgonistMedicine	1989	25

Page 1